Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 4;32(9):3025-3041.
doi: 10.1016/j.ymthe.2024.06.005. Epub 2024 Jun 12.

The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis

Affiliations

The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis

Qingtian Zhu et al. Mol Ther. .

Abstract

Efferocytosis, the clearance of apoptotic cells by macrophages, plays a crucial role in inflammatory responses and effectively prevents secondary necrosis. However, the mechanisms underlying efferocytosis in acute pancreatitis (AP) remain unclear. In this study, we demonstrated the presence of efferocytosis in injured human and mouse pancreatic tissues. We also observed significant upregulation of CD47, an efferocytosis-related the "do not eat me" molecule in injured acinar cells. Subsequently, we used CRISPR-Cas9 gene editing, anti-adeno-associated virus (AAV) gene modification, and anti-CD47 antibody to investigate the potential therapeutic role of AP. CD47 expression was negatively regulated by upstream miR133a, which is controlled by the transcription factor TRIM28. To further investigate the regulation of efferocytosis and reduction of pancreatic necrosis in AP, we used miR-133a-agomir and pancreas-specific AAV-shTRIM28 to modulate CD47 expression. Our findings confirmed that CD47-mediated efferocytosis is critical for preventing pancreatic necrosis and suggest that targeting the TRIM28-miR133a-CD47 axis is clinically relevant for the treatment of AP.

Keywords: acute pancreatitis; apoptotic cell clearance; clinical translation; immune microenvironment.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Similar articles

Cited by

References

    1. Mederos M.A., Reber H.A., Girgis M.D. Acute Pancreatitis: A Review. Jama. 2021;325:382–390. - PubMed
    1. Sah R.P., Garg P., Saluja A.K. Pathogenic mechanisms of acute pancreatitis. Curr. Opin. Gastroenterol. 2012;28:507–515. - PMC - PubMed
    1. Talukdar R., Sareen A., Zhu H., Yuan Z., Dixit A., Cheema H., George J., Barlass U., Sah R., Garg S.K., et al. Release of Cathepsin B in Cytosol Causes Cell Death in Acute Pancreatitis. Gastroenterology. 2016;151:747–758.e5. - PMC - PubMed
    1. Sendler M., Dummer A., Weiss F.U., Krüger B., Wartmann T., Scharffetter-Kochanek K., van Rooijen N., Malla S.R., Aghdassi A., Halangk W., et al. Tumour necrosis factor α secretion induces protease activation and acinar cell necrosis in acute experimental pancreatitis in mice. Gut. 2013;62:430–439. - PubMed
    1. Sendler M., Weiss F.U., Golchert J., Homuth G., van den Brandt C., Mahajan U.M., Partecke L.I., Döring P., Gukovsky I., Gukovskaya A.S., et al. Cathepsin B-Mediated Activation of Trypsinogen in Endocytosing Macrophages Increases Severity of Pancreatitis in Mice. Gastroenterology. 2018;154:704–718.e10. - PMC - PubMed

MeSH terms

LinkOut - more resources